Ergo Science ROE 1971-1970 | ERGN
Current and historical return on equity (ROE) values for Ergo Science (ERGN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Ergo Science ROE - Return on Equity Historical Data |
Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
Sector |
Industry |
Market Cap |
Revenue |
Business Services |
Business Information Services |
$0.000B |
$0.000B |
ERGO SCIENCE CORP. is developing novel treatments for metabolic and immune system disorders including Type II diabetes and obesity.
|